APR 22, 2020 3:03 PM PDT

Scientists Engineer Custom Antiviral Receptors to Fight COVID-19

WRITTEN BY: Kara Marker

The best offense may be a good defense in the fight against COVID-19. Researchers from the Duke-NUS Medical School are exploring the potential to reinforce the human immune system to become at least one component of a multi-faceted attack against COVID-19. The strategy is derived from immunotherapy approaches that have been successful in the past at treating cancer patients.

Immunotherapy is an approach that harnesses and bolsters an individual’s own immune system, providing necessary tools and empowering the human body to defeat cancer on its own. The same could potentially work for COVID-19, the disease caused by the virus SARS-CoV-2 and which leads to harmful complications for many individuals. Immunotherapy could work to treat COVID-19 and other infectious diseases.

Similar immunotherapies to those used in cancer patients have also been used to treat Hepatitis B (HBV) and other infectious diseases in the past. The technique revolves around extracting and altering important cells from the immune system: T cells.

"We demonstrated that T cells can be redirected to target the coronavirus responsible for SARS. Our team has now begun exploring the potential of CAR/TCR T cell immunotherapy for controlling the COVID-19-causing virus, SARS-CoV-2, and protecting patients from its symptomatic effects," explained senior author Antonio Bertoletti.

In theory, researchers would extract T cells from the circulation of an infected person and return them once they have “pasted” one of two receptor types onto each individual cell:

  1. T cell receptors (TCRs): Receptors naturally found on the surfaces of T cells
  2. Chimeric antigen receptors (CARs): Artificial TCRs created in the lab via mRNA electroporation

Either receptor type boosts T cells’ natural ability to recognize pathogens, like SARS-CoV-2, and cancerous cells. The technique of mRNA electroporation to create CARs “limits their functional activity to a short period of time” to protect patients with chronic viral diseases from “friendly fire” due to an excessive immune response triggered by the immunotherapy.

“We argue that some infections, such as HIV and HBV, can be a perfect target for this therapy, especially if lymphocytes are engineered using an approach that keeps them active for a limited amount of time to minimize potential side effects," explained lead author Dr. Anthony Tanoto Tan.

While there are vaccines to prevent HBV infection, current treatments for existing infections cure less than five percent of patients, as the best that these treatments can do is stop existing virally-infected cells from continuing to replicate.

A few roadblocks temporarily stand in the way from researchers implementing this type of therapy for COVID-19:

  • Need for specialized personnel and equipment
  • Issues with cost-effectiveness
  • Need for indefinite administration of immunotherapy

While researchers work to develop solutions and paths forward, they are considering at least using a combination treatment of anti-viral and CAR/TCR T cell immunotherapy.

Sources: Duke-NUS Medical School, Journal of Experimental Medicine, Journal of the Royal Society of Medicine

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 07, 2020
FEB 07, 2020
Eating Fruits and Vegetables May Lower Alzheimer's Risk
New research has found that flavonols, a large class of compounds present in many fruits and vegetables, may be linked t ...
MAR 19, 2020
Drug Discovery & Development
MAR 19, 2020
Could a 1949 Malaria Drug Treat COVID-19?
In the race to halt the current coronavirus pandemic, scientists, health experts and even Elon Musk are considering chlo ...
APR 20, 2020
APR 20, 2020
Making Sense of the T Cell Response Spectrum
T cells go through a sort of “training” process throughout life, and scientists recently discovered that the ...
MAY 03, 2020
MAY 03, 2020
Understanding How Lyme Disease Persists in the Body
Lyme disease is a confounding illness that can be difficult to diagnose, and can cause a wide range of serious health pr ...
MAY 05, 2020
MAY 05, 2020
Winter the Llama: An Unlikely Hero in the Fight Against COVID-19
A new hero in the fight against COVID-19 has emerged: 4-year-old Winter, a llama that currently resides in the Belgian c ...
MAY 15, 2020
MAY 15, 2020
Support the Microbiome So the Immune System Can Do Its Job
Research has long connected the human microbiome and immune system function, and now a recent study pinpoints a key poin ...
Loading Comments...